参考文献/References:
1 Marom EM,Sarvis S,Herndon JE,et al.T1 lung cancers:sensitivity of diagnosis with fluorodeoxyglucose PET.Radiology,2002,223(2):453-459.
2 Lowe V J,Fletcher JW,Gobar L,et al.Prospective investigation of positron emission tomography in lung nodules.J Clin Oncol,1998,16(3):1075-1084.
3 Erasmus JJ,McAdams HP,Rossi SE,et al.FDG PET of pleural effusions in patients with non-small cell lung cancer.Am J Roentgenol,2000,175(1):245-249.
4 Reed CE,Harpole DH,Posther KE,et al.Results of the American College of Surgeons Oncology Group Z0050 trial:the utility of positron emission tomography in staging potentially operable nonsmall cell lung cancer.J Thorac Cardiovasc Surg,2003,126(6):1943-1951.
5 Sasaki M,Kuwabara Y,Yoshida T,et al.Comparison of MET-PET and FDG-PET for differentiation between benign lesions and malignant tumors of the lung.Ann Nucl Med,2001,15(5):425-431.
6 Kubota K,Yamada S,Ishiwata K,et al.Evaluation of the treatment response of lung cancer with positron emission tomography and L-[methyl-11C]methionine:a preliminary study.Eur J Nucl Med,1993,20(6):495-501.
7 Pieterman R,Willemsen A,Appel M,et al.Visualisation and assessment of the protein synthesis rate of lung cancer using carbon-11tyrosine and positron emission tomography.Eur J Nucl Med Mol Imaging,2002,29(2):243-247.
8 Buck AK,Halter G,Schirrmeister H,et al.Imaging proliferation in lung tumors with PET:11C-FLT versus 11C-FDG.J Nucl Med,2003,44(9):1426-1431.
9 Vesselle H,Grierson J,Muzi M,et al.In vivo validation of 3’deoxy-3’-[(18)F]fluorothymidine ([(18)F]FLT) as a proliferation imaging tracer in humans:correlation of[(18)F]FLT uptake by positron emission tomography with Ki-67 immunohistochemistry and flow cytometry in human lung tumors.Clin Cancer Res,2002,8(11):3315-3323.
10 Avril N,Rose CA,Schelling M,et al.Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose:use and limitations.J Clin Oncol,2000,18(20):3495-3502.
11 Greco M,Crippa F,Agresti R,et al.Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography:clinical evaluation and alternative management.J Natl Cancer Inst,2001,93(8):630-635.
12 Bender H,Kirst J,Palmedo H,et al.Value of F-18 fluorodeoxyglucose positron emission tomography in the staging of recurrent breast carcinoma.Anticancer Res,1997,17(3B):1687-1692.
13 Dehdashti F,Flanagan FL,Mortimer JE,et al.Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy.Eur J Nucl Med,1999,26(1):51-56.
14 Wudel LJ Jr,Delbeke D,Morris D,et al.The role of[11C]fluorodeoxyglucose positron emission tomography imaging in the evaluation of hepatocellular carcinoma.Am Surg,2003,69(2):117-124.
15 Sugiyama M,Sakahara H,Torizuka T,et al.11C-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.J Gastroenterol,2004,39(10):961-968.
16 Kong YH,Han CJ,Lee SD,et al.Positron emission tomography with fluorine-18-fluorodeoxyglucose is useful for predicting the prognosis of patients with hepatocellular carcinoma.Korean J Hepatol,2004,10(4):279-287.
17 Ho CL,Yu SC,Yeung DW.11C-acetate PET imaging in hepatocellular carcinomaand otherliver masses.J Nucl Med,2003,44(2):213-221.
18 Chen YR,Li WX,Lin YR,et al.Value of 11C-FDG PET imaging in diagnosing tumor residue of intracranial glioma after surgery and radiotherapy.Ai Zheng,2004,23(10):1210-1212.
19 Spence AM,Muzi M,Mankoff DA,et al.11C-FDG PET of gliomas at delayed intervals:improved distinction between tumor and normal gray matter.J Nucl Med,2004,45(10):1653-1659.
20 Chung JK,Kim YK,Kim SK,et al.Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-or isometabolic on 11C-FDG PET[J].Eur J Nucl Med Mol Imaging,2002,29(2):176-182.
21 Van Laere K,Ceyssens S,Van Calenbergh F,et al.Direct comparison of (18)F-FDG and (11)C-methionine PET in suspected recurrence of glioma:sensitivity,inter-observer variability and prognostic value.EurJ Nucl Med Mol Imaging,2005,32(1):39-51.
22 Popperl G,Gotz C,Rachinger W,et al.Value of O-(2-[(18)F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma.Eur J Nucl Med Mol Imaging,2004,31(11):1464-1470.
23 Ohtani T,Kurihara H,Ishiuchi S,et al.Brain tumor imaging with carbon-11 choline:comparison with FDG PET and gadolinium-enhanced MR imaging.EurJ Nucl Med,2001,28(11):1664-1670.
24 van Waarde A,Cobben DC,Suurmeijer AJ,et al.Selectivity of 18F-FLT and 18F-FDG for differentiating tumor from inflammation in a rodent model.J Nucl Med,2004,45(4):695-700.
25 de Jong IJ,Pruim J,Elsinga PH,et al.11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.Eur Urol,2003,44(1):32-38.
26 de Jong IJ,Pruim J,Elsinga PH,et al.Visualization of prostate cancer with positron emission tomography.Eur Urol,2002,42(1):18-23.
27 de Jong IJ,Pruim J,Elsinga PH,et al.Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.J Nucl Med,2003,44(3):331-335.
28 Oyama N,Akino H,Kanamaru H,et al.11C-acetate PET imaging of prostate cancer.J Nucl Med,2002,43(2):181-186.
29 Kotzerke J,Volkmer BG,Neumaier B,et al.Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer.EurJ Nucl Med Mol Imaging,2002,29(10):1380-1384.
30 Kato T,Tsukamoto E,Kuge Y,et al.Accumulation of[11C]acetate in normal prostate and benign prostatic hyperplasia:comparison with prostate cancer.Eur J Nucl Med Mol Imaging,2002,29(11):1492-1495.
31 Larson SM,Morris M,Gunther I,et al.Tumor localization of 16beta-11C-fluoro-5alpha-dihydrotestosterone versus 11C-FDG in patients with progressive,metastatic prostate cancer.J Nucl Med,2004,45(3):366-373.
32 Yamamoto F,Tsukamoto E,Nakada K,et al.11C-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin’s lymphoma.Ann Nucl Mod,2004,18(6):519-526.
33 Allen-Auerbach M,Quon A,Weber WA,et al.Comparison between2-deoxy-2-[11C]fluoro-D-Glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma.Mol Imaging Biol,2004,6(6):411-416.
34 Kazama T,Faria SC,Varavithya V,et al.FDG PET in the evaluation of treatment for lymphoma:clinical usefulness and pitfalls.Radiographics,2005,25(1):191-207.
35 Wagner M,Seitz U,Buck A,et al.3’-[11C]fluoro-3’-deoxythymidine([11C]-FLT) as positron emission tomography tracer for imaging proliferation in a murine B-Cell lymphoma model and in the human disease.Cancer Res,2003,63(10):2681-2687.
36 Reinhardt MJ,Kubota K,Yamada S,et al.Assessment of cancer recurrence in residual tumors after fractionated radiotherapy:a comparison of fluorodeoxyglucose,L-methionine and thymidine.J Nucl Med,1997,38(2):280-287.
37 van Kouwen M,Jansen JB,van Goor H,et al.FDG-PET is able to detect pancreatic carcinoma in chronic pancreatitis.Eur J Nucl Med Mol Imaging,2005,32(4):399-404.
38 Nakamoto Y,Higashi T,Sakahara H,et al.Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas.Cancer,2000,89(12):2547-2554.
39 Diederichs CG,Staib L,Glatting G,et al.FDG PET:elevated plasma glucose reduces beth uptake and detection rate of pancreatic malignancies.J Nucl Med,1998,39(6):1030-1033.
40 Tang GH,Wang MF,Tang XL,et al.Synthesis and radiopharmacology of S-(2-18F-fluoroethyl)-L-methionine for tumor imaging.Yao Xue Xue Bao,2003,38(12):915-918.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]周玉祥,蓝博文,黄春榆,等.64排螺旋CT冠状动脉血管成像诊断冠状动脉-肺动脉瘘的应用价值[J].国际放射医学核医学杂志,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
Zhou Yuxiang,Lan Bowen,Huang Chunyu,et al.Clinical value of coronary artery-pulmonary artery fistula revealed by 64-slice spiral CT coronary angiography[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):26.[doi:10.3760/cma.j.issn.1673-4114.2016.01.006]
[3]陈超坤,刘亮,傅飞先,等.囊性胸腺瘤和囊性畸胎瘤的影像学特征及鉴别诊断[J].国际放射医学核医学杂志,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
Chen Chaokun,Liu Liang,Fu Feixian,et al.Imaging features and differential diagnosis of cystic thymoma and cystic teratoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):31.[doi:10.3760/cma.j.issn.1673-4114.2016.01.007]
[4]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[5]岳进,苏丽萍.全身MRI与PET/CT在淋巴瘤骨髓浸润诊断及预后中的作用[J].国际放射医学核医学杂志,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
Yue Jin,Su Lipin.Function of whole-body MRI and PET/CT in the diagnosis and prognosis of lymphoma with bone marrow infiltration[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):50.[doi:10.3760/cma.j.issn.1673-4114.2016.01.010]
[6]张莹莹,王振光,孔艳.PET/CT显像在肺间质纤维化中的应用进展[J].国际放射医学核医学杂志,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
Zhang Yingying,Wang Zhenguang,Kong Yan.Application advancement on PET/CT in pulmonary interstitial fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):55.[doi:10.3760/cma.j.issn.1673-4114.2016.01.011]
[7]麦卫平,张永林.能谱CT成像在肺癌诊断中的应用研究进展[J].国际放射医学核医学杂志,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
Mai Weiping,Zhang Yonglin.Research progress of spectral imaging in the diagnosis of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):77.[doi:10.3760/cma.j.issn.1673-4114.2016.01.015]
[8]史文杰,孟召伟,谭建.基于Deauville标准探讨18F-FDG PET/CT在霍奇金淋巴瘤复发诊断中的应用价值[J].国际放射医学核医学杂志,2016,40(2):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
Shi Wenjie,Meng Zhaowei,Tan Jian.Value of 18F-FDG PET/CT on diagnosis of Hodgkin lymphoma recurrence using Deauville criterion[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):120.[doi:10.3760/cma.j.issn.1673-4114.2016.02.007]
[9]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[10]周翠屏,廖俊杰,何国华,等.原发性肠系膜巨大淋巴结增生症的MSCT表现与病理对照分析[J].国际放射医学核医学杂志,2016,40(3):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
Zhou Cuiping,Liao Junjie,He Guohua,et al.Primary mesenteric Castleman disease:MSCT findings with histopathologic correlation[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(1):175.[doi:10.3760/cma.j.issn.1673-4114.2016.03.003]
[11]陆东燕,侯莎莎,丁恩慈,等.结核性与恶性腹膜弥漫性病变的18F-FDG PET/CT影像特征分析[J].国际放射医学核医学杂志,2014,38(6):398.[doi:10.3760/cma.j.issn.1673-4114.2014.06.012]
Lu Dong-yan,Hou Sha-sha,Ding En-ci,et al.Analysis of 18F-FDG PET/CT imaging features of tuberculous and cancerous diffuse peritoneal lesions[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(1):398.[doi:10.3760/cma.j.issn.1673-4114.2014.06.012]
[12]刘春利,李毅红.18F-FDG PET/CT在原发灶不明的脑转移瘤中的诊断价值[J].国际放射医学核医学杂志,2013,37(2):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
LIU Chun-li,LI Yi-hong.The value of 18F-FDG PET/CT in diagnosing brain metastases from unknown primary tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):92.[doi:10.3760/cma.j.issn.1673-4114.2013.02.008]
[13]王胜军,杨卫东,赵小虎,等.18F-FDG PET/CT诊断多发癌的价值[J].国际放射医学核医学杂志,2013,37(2):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
WANG Sheng-jun,YANG Wei-dong,ZHAO Xiao-hu,et al.Value of 18F-FDG PET/CT in the diagnosis of multiple primary malignant neoplasms[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):96.[doi:10.3760/cma.j.issn.1673-4114.2013.02.009]
[14]唐宇辉,陈跃.PET/CT在儿科恶性肿瘤中的应用进展[J].国际放射医学核医学杂志,2013,37(2):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
TANG Yu-hui,CHEN Yue.The progression of PET/CT in pediatric malignant tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):107.[doi:10.3760/cma.j.issn.1673-4114.2013.02.012]
[15]孙爱君,任茜,刘健,等.11C-乙酸盐PET和PET/CT在肿瘤显像中的应用[J].国际放射医学核医学杂志,2013,37(4):243.[doi:10.3760/cma.j.issn.1673-4114.2013.04.013]
SUN Ai-jun,REN Qian,LIU Jian,et al.The application of 11C-acetate PET and PET-CT for tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):243.[doi:10.3760/cma.j.issn.1673-4114.2013.04.013]
[16]辛军,赵周社,李红,等.自适应统计迭代重建技术在PET/CT全身扫描中的应用[J].国际放射医学核医学杂志,2013,37(5):279.[doi:10.3760/cma.j.issn.1673-4114.2013.05.007]
XIN Jun,ZHAO Zhou-she,LI Hong,et al.Adaptive statistical iterative reconstruction technology in the application of PET/CT whole body scans[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(1):279.[doi:10.3760/cma.j.issn.1673-4114.2013.05.007]
[17]汪会,徐慧琴.肿瘤乏氧显像剂的研究进展[J].国际放射医学核医学杂志,2012,36(6):366.[doi:10.3760/cma.j.issn.1673-4114.2012.06.011]
WANG Hui,XU Hui-qin.Advances in study of tumor hypoxia imaging agents[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(1):366.[doi:10.3760/cma.j.issn.1673-4114.2012.06.011]
[18]汪太松,赵晋华,宋建华.PET-MRI和多模式肿瘤显像[J].国际放射医学核医学杂志,2011,35(5):261.[doi:10.3760/cma.j.issn.1673-4114.2011.05.002]
WANG Tai-song,ZHAO Jin-hua,SONG Jian-hua.PET-MRI and multimodal cancer imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):261.[doi:10.3760/cma.j.issn.1673-4114.2011.05.002]
[19]周敏,魏秋霞,林俊杰,等.良恶性肿瘤18F-FDG符合线路显像的临床价值[J].国际放射医学核医学杂志,2011,35(5):279.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
ZHOU Min,WEI Qiu-xia,LIN Jun-jie,et al.18F-FDG coincidence imaging for the detection of benign and malignant neoplasm[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):279.[doi:10.3760/cma.j.issn.1673-4114.2011.05.006]
[20]凌萍,张旭光,涂彧.纳米金在肿瘤显像与放射治疗中的应用[J].国际放射医学核医学杂志,2011,35(1):58.[doi:10.3760/cma.j.issn.1673-4114.2011.01.016]
LING Ping,ZHANG Xu-guang,TU Yu.The application of nanogold in tumor imaging and radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(1):58.[doi:10.3760/cma.j.issn.1673-4114.2011.01.016]